top of page

Cottilion Group

Public·4 members

  • The global incident detection video content analytics market size was valued at USD 11.69 billion in 2025 and is expected to reach USD 50.62 billion by 2033, at a CAGR of 20.10% during the forecast period

  • The market growth is largely fuelled by the rising adoption of AI-driven surveillance solutions, increasing demand for real-time threat detection, and the expansion of smart city projects worldwide

  • Growing need for automated monitoring across transportation, commercial infrastructure, and public safety environments is further accelerating market adoption


2 Views
  • The global digestive enzymes market size was valued at USD 994.52 million in 2025 and is expected to reach USD 2,010.91 million by 2033, at a CAGR of 9.20% during the forecast period

  • The market growth is largely fueled by increasing awareness regarding digestive health, rising prevalence of gastrointestinal disorders, and growing adoption of dietary supplements across diverse age groups, leading to higher demand in both clinical and consumer health segments

  • Furthermore, expanding applications in functional foods, pharmaceuticals, and nutraceuticals, along with rising consumer preference for natural and plant-based enzyme formulations, are establishing digestive enzymes as an essential component of modern digestive care solutions. These converging factors are accelerating the uptake of digestive enzyme products, thereby significantly boosting the industry's growth


1 View

Exploring the Clinical Utility and Technological Landscape of Genomic Material Analysis in Urine Samples for Disease

Genomic Urine Testing" represents a significant leap forward in non-invasive diagnostics, particularly for urological cancers like bladder and prostate carcinoma. This technology focuses on isolating and analyzing nucleic acids, specifically cell-free DNA (cfDNA) and cell-free RNA (cfRNA), which are shed by tumor cells into the urinary tract. The urine sample provides an easily accessible and non-invasive reservoir of genomic material that can harbor cancer-specific mutations, methylation patterns, and other molecular signatures, making it a powerful tool for early-stage detection and recurrence monitoring without the need for tissue biopsies or cystoscopy.

The analysis typically involves highly sensitive techniques like Next-Generation Sequencing (NGS) and droplet digital PCR (ddPCR) to detect minute quantities of tumor-derived DNA fragments. The challenge lies in distinguishing true cancerous signals from background noise, which requires sophisticated bioinformatics pipelines. Unlike traditional cytology, which relies on morphologic assessment, genomic testing provides an objective molecular profile, offering greater sensitivity and specificity…


11 Views

Welcome to our group Cottilion Group! A space for us to connect and share with each other. Start by posting your thoughts, sharing media, or creating a poll.

    bottom of page